Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Spruce Biosciences (SPRB) Interest & Investment Income (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Interest & Investment Income for 4 consecutive years, with -$40000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 107.01% to -$40000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $1.1 million, a 66.77% decrease, with the full-year FY2025 number at $1.1 million, down 66.77% from a year prior.
  • Interest & Investment Income was -$40000.0 for Q4 2025 at Spruce Biosciences, down from $36000.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $1.4 million in Q3 2023 to a low of -$40000.0 in Q4 2025.
  • A 4-year average of $664937.5 and a median of $612500.0 in 2024 define the central range for Interest & Investment Income.
  • Peak YoY movement for Interest & Investment Income: soared 1125.96% in 2023, then crashed 107.01% in 2025.
  • Spruce Biosciences' Interest & Investment Income stood at $1.1 million in 2022, then grew by 20.55% to $1.3 million in 2023, then tumbled by 56.74% to $571000.0 in 2024, then plummeted by 107.01% to -$40000.0 in 2025.
  • Per Business Quant, the three most recent readings for SPRB's Interest & Investment Income are -$40000.0 (Q4 2025), $36000.0 (Q3 2025), and $654000.0 (Q2 2025).